CTS Corp banner

CTS Corp
NYSE:CTS

Watchlist Manager
CTS Corp Logo
CTS Corp
NYSE:CTS
Watchlist
Price: 57.29 USD 3.08% Market Closed
Market Cap: $1.7B

CTS Corp
Investor Relations

CTS Corporation, with its roots tracing back to the late 19th century, has evolved into a significant player in the realm of electronic components and technology manufacturing. Founded in 1896 in Elkhart, Indiana, the company initially focused on producing resilient potentiometers for radios and other electronics as these technologies burgeoned. Over time, CTS strategically diversified its product offerings, aligning with the swift pace of advancements in various sectors. Today, its core operations revolve around designing and manufacturing complex sensor and connectivity devices, alongside components critical to communication infrastructure, automotive, industrial, defense, and aerospace sectors.

In crafting value, CTS leverages its engineering prowess, developing products that cater to the precise needs of its clientele. The company's revenue model is deeply intertwined with its ability to integrate state-of-the-art materials science and cutting-edge engineering processes. By investing in research and development, CTS ensures its products meet the exacting standards required in demanding environments, carving out a niche where precision and reliability are paramount. This strategic focus allows CTS to maintain robust customer relationships globally, ensuring its components are crucial in an ever-expanding array of advanced technologies that power modern society.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 10, 2026
AI Summary
Q4 2025

Revenue Growth: CTS delivered Q4 revenue of $137 million, up 9% year-over-year, with diversified end markets growing 16%.

Diversification: Diversified markets made up almost 60% of total revenue, supporting CTS's strategic shift away from transportation.

Profitability: Adjusted gross margin improved by 150 basis points in Q4, reaching 39.1%, driven by operational improvements and mix.

EPS Performance: Adjusted diluted EPS for Q4 was $0.62, up from $0.50 last year; full-year adjusted EPS reached $2.23.

2026 Guidance: Management expects 2026 sales of $550–580 million and adjusted diluted EPS of $2.30–2.45.

Medical and Industrial Strength: Medical market sales rose 41% in Q4; industrial sales increased 16%, both showing continued growth momentum.

Transportation Headwinds: Transportation sales fell 7% for the full year, but new business awards reached $100 million in Q4.

Capital Returns: CTS returned $62 million to shareholders in 2025 through dividends and buybacks.

Key Financials
Revenue
$137 million
Revenue (Full Year)
$541 million
Diversified End Market Sales (Q4)
59% of total revenue
Diversified End Market Sales (Full Year)
57% of total revenue
Book-to-Bill Ratio (Q4)
1
Book-to-Bill Ratio (Full Year)
1.04
Adjusted Gross Margin (Q4)
39.1%
Adjusted Gross Margin (Full Year)
38.5%
Adjusted EBITDA Margin (Full Year)
22.8%
Adjusted Diluted EPS (Q4)
$0.62
Diluted EPS (Q4)
$0.67
Adjusted Diluted EPS (Full Year)
$2.23
Diluted EPS (Full Year)
$2.19
Operating Cash Flow (Q4)
$29 million
Operating Cash Flow (Full Year)
$102 million
Cash Balance (End of 2025)
$82 million
Borrowings (End of 2025)
$58 million
Shares Repurchased (Q4)
398,000 shares ($17 million)
Shares Repurchased (Full Year)
1.4 million shares ($57 million)
Capital Returned to Shareholders
$62 million in 2025
Share Repurchase Authorization Remaining
$90 million
Medical Sales (Q4)
up 41% YoY
Medical Sales (Full Year)
$85 million
Medical Bookings (Q4)
up 37% YoY
Medical Book-to-Bill Ratio (Full Year)
1.07
Aerospace & Defense Sales (Full Year)
$83 million
Aerospace & Defense Sales (Q4)
down 4% YoY
Aerospace & Defense Bookings (Full Year)
up 15%
Industrial Sales (Q4)
up 16% YoY
Industrial Sales (Full Year)
$140 million
Industrial Bookings (Q4)
up 22% YoY
Industrial Book-to-Bill Ratio (Full Year)
1.11
Transportation Sales (Full Year)
$234 million
Transportation Sales (Q4)
$56 million
New Business Awards (Transportation, Q4)
$100 million
Total Booked Business (End of Q4)
$1 billion
Other Earnings Calls

Management

Mr. Kieran M. O'Sullivan
Chairman, President & CEO
No Bio Available
Mr. Ashish Agrawal
VP, CFO & Principal Accounting Officer
No Bio Available
Mr. Scott L. D'Angelo
VP, General Counsel & Secretary
No Bio Available
Mr. Mitchell J. Walorski
Director of Investor Relations
No Bio Available
Pratik Trivedi
Senior Vice President
No Bio Available

Contacts

Address
ILLINOIS
Lisle
4925 Indiana Ave
Contacts
+16305778800.0
www.ctscorp.com